SCHEMBL269353

SCHEMBL269353

CC(=O)CCc1ccccc1O

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IAPP P10997 4/20 0.72
ALDH1A1 P00352 2/20 0.56
LMNA P02545 1/20 0.56
TAAR1 Q96RJ0 1/20 0.52
AKR1B1 P15121 1/20 0.52
NPC1 O15118 1/20 0.49
PKM P14618 1/20 0.49
RAB9A P51151 1/20 0.49
HSPA5 P11021 1/20 0.48
HTR1A P08908 1/20 0.47
MPO P05164 2/20 0.46
TYR P14679 1/20 0.44
CYP2D6 P10635 1/20 0.43
TSHR P16473 1/20 0.43
HIF1A Q16665 1/20 0.43
MGLL Q99685 1/20 0.43
CYP4F2 P78329 1/20 0.43
CYP4A11 Q02928 1/20 0.43
SLC6A4 P31645 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29934495 1.00 IAPP (0.72) IAPPALDH1A1LMNATAAR1AKR1B1
SCHEMBL29191321 0.88 IAPP (0.58) IAPPALDH1A1LMNATAAR1AKR1B1
SCHEMBL14935706 0.86 IAPP (0.56) IAPPALDH1A1TAAR1AKR1B1MPO
SCHEMBL9343713 0.85 IAPP (0.54) IAPPALDH1A1TAAR1AKR1B1MPO
SCHEMBL26046392 0.84 IAPP (1.00) IAPPALDH1A1LMNA
SCHEMBL26046394 0.83 CYP4F2 (0.61) IAPPALDH1A1LMNACYP4F2CYP4A11
SCHEMBL11751573 0.83 IAPP (0.59) IAPPTAAR1AKR1B1NPC1PKM
SCHEMBL1404914 0.81 IAPP (0.69) IAPPALDH1A1LMNAAKR1B1NPC1
SCHEMBL29373796 0.81 AKR1B1 (0.65) IAPPTAAR1AKR1B1NPC1PKM
SCHEMBL7128255 0.81 AKR1B1 (0.65) IAPPTAAR1AKR1B1NPC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119032180-A Process for preparing a compound having formula (I) by fermentation 法国特种经营公司 2024-11-26 CN claimed
CN-115322109-B Preparation method of dobutamine hydrochloride suitable for industrial production 安徽恒星制药有限公司 2024-02-27 CN claimed
CN-104326919-A Compound 2-hydroxy-3-fluoro-5-nitro-1-phenyl butanone and preparation method and agricultural biological activity thereof UNIV QINGDAO AGRICULTURAL 2015-02-04 CN claimed
CN-1882307-A Method for dyeing fibres containing keratine HENKEL KGAA (DE) 2006-12-20 CN claimed
EP-1716159-A2 CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS General Electronic Company (US) 2006-11-02 EP claimed
CN-1213013-C Process for synthesizing 1-ortho-hydroxyphenyl butanone LAIYANG AGRICULTURAL COLLEGE (CN) 2005-08-03 CN claimed
WO-2005066186-A2 CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS GENERAL ELECTRIC COMPANY (US) 2005-07-21 WO claimed
EP-0946700-A1 RINSE-ADDED AND DRYER-ADDED FABRIC SOFTENING COMPOSITIONS AND METHOD OF USE FOR THE DELIVERY OF ESTER FRAGRANCE DERIVATIVES THE PROCTER & GAMBLE COMPANY (US) 1999-10-06 EP claimed
WO-1998027191-A1 RINSE-ADDED AND DRYER-ADDED FABRIC SOFTENING COMPOSITIONS AND METHOD OF USE FOR THE DELIVERY OF ESTER FRAGRANCE DERIVATIVES THE PROCTER & GAMBLE COMPANY (US) 1998-06-25 WO claimed
CN-122094649-A Personal care compositions 2026-05-26 CN disclosed
EP-4021588-B1 PERSONAL CARE COMPOSITIONS COLGATE PALMOLIVE CO (US) 2026-02-04 EP disclosed
CN-119970535-A Fluoride-free anti-caries dental oral care compositions 宝洁公司 2025-05-13 CN disclosed
CN-119970534-A Fluoride-free anti-caries dental oral care compositions 宝洁公司 2025-05-13 CN disclosed
CN-114025735-B Oral care compositions comprising tin ions 宝洁公司 2025-05-02 CN disclosed
EP-1889907-A1 NOVEL AMINO GROUP TRANSFERASE, GENE ENCODING THE SAME AND METHOD OF USING THE SAME Kaneka Corporation (JP) 2008-02-20 EP disclosed
US-20070042022-A1 Liquid formulations of ractopamine JPMORGAN CHASE BANK, N.A., AS SUCCESSOR COLLATERAL AGENT 2007-02-22 US disclosed
CN-1882307-A Method for dyeing fibres containing keratine HENKEL KGAA (DE) 2006-12-20 CN disclosed
EP-1672985-A1 LIQUID FORMULATIONS OF RACTOPAMINE ELI LILLY AND COMPANY (US) 2006-06-28 EP disclosed
WO-2005036980-A1 LIQUID FORMULATIONS OF RACTOPAMINE ELI LILLY AND COMPANY (US) 2005-04-28 WO disclosed
EP-0038480-B1 PROCESS FOR THE PREPARATION OF 1-(4-HYDROXYPHENYL)-3-BUTANONE AND INTERMEDIATE COMPOUNDS FOR THIS PROCESS BASF Aktiengesellschaft (DE) 1983-09-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070042022-A1 Liquid formulations of ractopamine SLC6A12, SLC6A2, SLC6A7 IAPP 679/4885ALDH1A1 3546/4885LMNA 2859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.